Jalen Johnson

#1 SF

Atlanta Hawks

Status

GTD - Ankle - Sprain Expected Return: 2024-10-01

Previous game (vs. MIA 4/9)

PTS

REB

AST

BLK

STL

Latest Jalen Johnson news

The Hawks announced Thursday that Johnson has been diagnosed with a Grade 2 lateral ankle sprain and will be re-evaluated in approximately three weeks. Johnson exited Tuesday's game against Miami due to his ankle injury, and he's facing a multi-week absence following the results of his MRI. Whether Johnson will be back in action at any point during postseason play likely depends on whether the Hawks advance past the Play-In Tournament. In Johnson's absence, Vit Krejci, De'Andre Hunter (rest) and Wesley Matthews (hamstring) could see increased roles.

2023-24 Season Stats

PTS

REB

AST

BLK

STL

16.0

8.7

3.6

0.8

1.2

1.8

Career Averages

PTS

REB

AST

BLK

STL

9.1

5.4

2.0

0.6

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	56	52	33.7	16.0	8.7	3.6	0.8	1.2	1.8	19	1	1.3	3.6	35.5%	5.1	9.0	57.4%	6.4	12.5	51.1%	1.9	2.6	72.8%	1.3	7.4	2.4	2.0	-76	58.4%
2022-23	70	6	14.9	5.6	4.0	1.2	0.5	0.5	0.6	1	0	0.4	1.5	28.8%	1.8	3.1	58.7%	2.3	4.6	49.1%	0.7	1.1	62.8%	0.7	3.3	1.6	2.0	-10	55.4%
2021-22	22	0	5.5	2.4	1.2	0.1	0.1	0.1	0.4	0	0	0.1	0.6	23.1%	0.9	1.3	67.9%	1.0	1.9	53.7%	0.2	0.3	71.4%	0.1	1.1	0.4	0.3	-19	59.0%
Career	148	58	20.6	9.1	5.4	2.0	0.6	0.7	1.0	20	1	0.7	2.1	32.8%	2.9	5.1	58.2%	3.6	7.2	50.6%	1.1	1.6	69.4%	0.9	4.5	1.7	1.9	-105	57.5%

Career Averages

PTS

REB

AST

BLK

STL

3.3

1.9

1.0

0.0

0.4

Year	GP	MIN	PTS	REB	AST	STL	TO	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2022-23	6	9.3	4.3	2.5	1.3	0.5	0.8	0.7	1.8	36.4%	1.0	2.2	46.2%	1.7	4.0	41.7%	0.3	0.3	100.0%	0.3	2.2	0.8	1.6	-3	52.3%
2021-22	2	4.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0%	0.0	1.0	0.0%	0.0	1.5	0.0%	0.0	0.0	0.0%	0.0	0.0	0.0	0.0	+6	0.0%
Career	8	8.1	3.3	1.9	1.0	0.4	0.8	0.5	1.5	33.3%	0.8	1.9	40.0%	1.3	3.4	37.0%	0.3	0.3	100.0%	0.3	1.6	0.6	1.3	+3	46.6%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/20	PHI	L 120-106	16	9	4	1	1	2	1	2	1	50.0%	6	3	50.0%	8	4	50.0%	0	0	0.0%	3	1	1.0	+16	6	7	56.3%
10/16	IND	L 116-112	24	4	3	3	0	0	1	0	0	0.0%	8	2	25.0%	8	2	25.0%	0	0	0.0%	0	3	3.0	-16	0	2	25.0%
10/14	NOP	W 110-105	16	12	3	7	0	2	2	2	1	50.0%	7	4	57.1%	9	5	55.6%	2	1	50.0%	0	3	3.5	+17	1	19	60.7%
10/12	MEM	W 103-102	17	14	3	3	0	2	0	2	2	100.0%	5	4	80.0%	7	6	85.7%	1	0	0.0%	0	3	0.0	+1	2	19	94.1%
10/10	CLE	W 108-107	21	7	7	3	1	0	1	1	0	0.0%	4	2	50.0%	5	2	40.0%	3	3	100.0%	1	6	3.0	-1	1	13	55.4%
Preseason Totals			19.3	9.2	4.0	3.4	0.4	1.2	1.0	1.4	0.8	57.1%	6.0	3.0	50.0%	7.4	3.8	51.4%	1.2	0.8	66.7%	0.8	3.2	3.4	+17	2.0	15.0	58.0%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/9	MIA	L 117-111	23	13	8	3	0	1	1	1	1	100.0%	6	5	83.3%	7	6	85.7%	0	0	0.0%	2	6	3.0	-14	2	21	92.9%
4/6	DEN	L 142-110	33	17	6	4	0	1	6	5	1	20.0%	13	7	53.8%	18	8	44.4%	0	0	0.0%	1	5	0.7	-8	0	11	47.2%
4/4	DAL	L 109-95	36	6	16	4	0	1	2	1	0	0.0%	11	3	27.3%	12	3	25.0%	0	0	0.0%	1	15	2.0	-11	1	13	25.0%
4/3	DET	W 121-113	36	28	14	11	1	4	3	4	2	50.0%	10	8	80.0%	14	10	71.4%	7	6	85.7%	2	12	3.7	+12	0	54	82.0%
4/1	CHI	W 113-101	24	11	4	1	0	2	1	5	2	40.0%	7	2	28.6%	12	4	33.3%	2	1	50.0%	1	3	1.0	+15	2	7	42.7%
3/18	LAL	L 136-105	32	25	9	4	1	0	1	11	2	18.2%	9	7	77.8%	20	9	45.0%	6	5	83.3%	2	7	4.0	-22	1	29	55.2%
3/17	LAC	W 110-93	36	18	12	6	2	3	1	3	3	100.0%	11	4	36.4%	14	7	50.0%	1	1	100.0%	1	11	6.0	+16	4	31	62.3%
3/15	UTA	L 124-122	34	26	5	5	0	0	3	8	4	50.0%	15	4	26.7%	23	8	34.8%	10	6	60.0%	1	4	1.7	-2	1	17	47.4%
3/6	CLE	W 112-101	19	7	4	4	1	0	1	2	1	50.0%	3	2	66.7%	5	3	60.0%	0	0	0.0%	0	4	4.0	+12	1	12	70.0%
3/5	NYK	W 116-100	38	26	9	7	0	1	1	3	2	66.7%	14	10	71.4%	17	12	70.6%	0	0	0.0%	1	8	7.0	+23	4	33	76.5%
3/2	BKN	L 114-102	34	7	9	1	0	0	1	4	0	0.0%	8	3	37.5%	12	3	25.0%	2	1	50.0%	2	7	1.0	-10	1	4	27.2%
2/29	BKN	L 124-97	32	14	5	0	2	0	2	4	1	25.0%	8	4	50.0%	12	5	41.7%	4	3	75.0%	1	4	0.0	-38	1	12	50.9%
2/27	UTA	W 124-97	35	22	13	6	0	1	5	4	2	50.0%	10	7	70.0%	14	9	64.3%	2	2	100.0%	0	13	1.2	+33	3	29	73.9%
2/25	ORL	W 109-92	38	21	10	7	2	1	0	5	2	40.0%	14	7	50.0%	19	9	47.4%	1	1	100.0%	2	8	0.0	+16	3	28	54.0%
2/23	TOR	L 123-121	37	12	12	4	3	1	1	2	0	0.0%	11	6	54.5%	13	6	46.2%	3	0	0.0%	3	9	4.0	+7	0	19	41.9%
2/14	CHA	L 122-99	37	19	12	0	2	0	2	5	0	0.0%	13	9	69.2%	18	9	50.0%	2	1	50.0%	5	7	0.0	-20	3	19	50.3%
2/12	CHI	L 136-126	34	13	8	2	0	0	0	2	0	0.0%	7	5	71.4%	9	5	55.6%	4	3	75.0%	1	7	0.0	-13	3	19	60.4%
2/10	HOU	W 122-113	39	21	6	3	2	2	2	2	1	50.0%	9	7	77.8%	11	8	72.7%	4	4	100.0%	2	4	1.5	+10	3	28	82.3%
2/9	PHI	W 127-121	38	11	11	6	2	0	1	4	1	25.0%	8	4	50.0%	12	5	41.7%	2	0	0.0%	0	11	6.0	+7	3	17	42.7%
2/7	BOS	L 125-117	36	19	15	4	0	3	2	5	2	40.0%	11	6	54.5%	16	8	50.0%	1	1	100.0%	2	13	2.0	+1	0	31	57.8%
2/5	LAC	L 149-144	37	9	7	5	1	0	1	3	1	33.3%	11	2	18.2%	14	3	21.4%	3	2	66.7%	1	6	5.0	-7	4	4	29.4%
2/3	GSW	W 141-134	43	21	13	8	1	0	0	6	2	33.3%	14	7	50.0%	20	9	45.0%	1	1	100.0%	3	10	0.0	-3	3	30	51.4%
2/2	PHX	W 129-120	37	16	7	4	1	1	1	6	2	33.3%	8	4	50.0%	14	6	42.9%	3	2	66.7%	0	7	4.0	-2	2	18	52.2%
1/30	LAL	W 138-122	34	19	11	3	0	3	0	2	1	50.0%	12	7	58.3%	14	8	57.1%	2	2	100.0%	1	10	0.0	+3	5	25	63.8%
1/28	TOR	W 126-125	41	17	12	5	0	2	2	4	1	25.0%	13	5	38.5%	17	6	35.3%	4	4	100.0%	3	9	2.5	+6	4	22	45.3%
1/26	DAL	L 148-143	37	25	3	3	1	1	0	3	2	66.7%	9	8	88.9%	12	10	83.3%	4	3	75.0%	0	3	0.0	+6	6	27	90.8%
1/24	GSW	L 134-112	36	21	9	6	0	1	0	6	2	33.3%	10	6	60.0%	16	8	50.0%	5	3	60.0%	1	8	0.0	-6	4	26	57.7%
1/22	SAC	L 122-107	37	11	7	0	2	1	0	7	1	14.3%	11	3	27.3%	18	4	22.2%	4	2	50.0%	2	5	0.0	-24	1	6	27.8%
1/20	CLE	L 116-95	33	20	7	4	2	1	1	5	1	20.0%	11	7	63.6%	16	8	50.0%	6	3	50.0%	1	6	4.0	-19	2	24	53.6%
1/19	MIA	W 109-108	33	15	7	2	0	2	2	4	1	25.0%	10	6	60.0%	14	7	50.0%	0	0	0.0%	2	5	1.0	+1	1	16	53.6%
1/17	ORL	W 106-104	38	10	9	3	0	2	4	2	1	50.0%	7	2	28.6%	9	3	33.3%	5	3	60.0%	0	9	0.8	+9	3	12	44.6%
1/15	SAS	W 109-99	37	16	10	7	0	6	5	2	1	50.0%	11	6	54.5%	13	7	53.8%	1	1	100.0%	0	10	1.4	+16	3	26	59.5%
1/13	WAS	L 127-99	35	5	6	3	2	0	4	3	1	33.3%	4	1	25.0%	7	2	28.6%	0	0	0.0%	0	6	0.8	-23	3	3	35.7%
1/12	IND	L 126-108	32	16	4	3	0	2	3	2	1	50.0%	9	6	66.7%	11	7	63.6%	3	1	33.3%	0	4	1.0	-17	3	17	64.9%
1/10	PHI	W 139-132	40	25	16	7	2	1	1	4	3	75.0%	9	5	55.6%	13	8	61.5%	6	6	100.0%	2	14	7.0	+6	3	47	79.9%
1/7	ORL	L 117-110	40	12	11	4	1	0	3	4	0	0.0%	8	6	75.0%	12	6	50.0%	0	0	0.0%	1	10	1.3	-20	6	11	50.0%
1/5	IND	L 150-116	29	12	8	3	0	1	0	4	1	25.0%	7	4	57.1%	11	5	45.5%	1	1	100.0%	1	7	0.0	-26	1	17	52.4%
1/3	OKC	W 141-138	28	28	7	3	0	4	1	4	2	50.0%	14	9	64.3%	18	11	61.1%	4	4	100.0%	1	6	3.0	-1	5	31	70.9%
12/31	WAS	W 130-126	36	24	13	4	0	0	1	4	2	50.0%	8	7	87.5%	12	9	75.0%	5	4	80.0%	0	13	4.0	-13	2	37	84.5%
12/29	SAC	L 117-110	35	16	15	4	1	0	4	4	1	25.0%	8	4	50.0%	12	5	41.7%	6	5	83.3%	2	13	1.0	-7	2	25	54.6%
12/26	CHI	L 118-113	29	10	9	4	0	1	2	1	0	0.0%	7	5	71.4%	8	5	62.5%	0	0	0.0%	3	6	2.0	-9	1	19	62.5%
11/25	WAS	W 136-108	8	8	1	1	1	2	0	2	1	50.0%	2	2	100.0%	4	3	75.0%	2	1	50.0%	1	0	0.0	+7	0	12	82.0%
11/22	BKN	W 147-145	40	7	6	3	1	2	5	2	1	50.0%	5	2	40.0%	7	3	42.9%	0	0	0.0%	0	6	0.6	-15	3	8	50.0%
11/21	IND	L 157-152	33	17	7	6	1	2	1	2	0	0.0%	10	6	60.0%	12	6	50.0%	5	5	100.0%	1	6	6.0	-4	2	26	59.9%
11/17	PHI	L 126-116	36	18	10	2	3	1	0	2	0	0.0%	10	7	70.0%	12	7	58.3%	4	4	100.0%	1	9	0.0	+3	2	28	65.4%
11/15	NYK	L 116-114	31	18	5	0	2	0	3	4	4	100.0%	5	3	60.0%	9	7	77.8%	0	0	0.0%	0	5	0.0	-13	1	20	100.0%
11/14	DET	W 126-120	35	16	5	1	1	1	2	2	2	100.0%	7	4	57.1%	9	6	66.7%	2	2	100.0%	1	4	0.5	+0	2	16	81.0%
11/11	MIA	L 117-109	21	9	4	2	0	0	3	3	1	33.3%	5	3	60.0%	8	4	50.0%	0	0	0.0%	0	4	0.7	-6	2	5	56.3%
11/9	ORL	W 120-119	30	19	9	2	1	0	3	4	2	50.0%	5	5	100.0%	9	7	77.8%	4	3	75.0%	2	7	0.7	+15	4	25	88.3%
11/6	OKC	L 126-117	33	13	12	5	1	3	0	4	0	0.0%	11	6	54.5%	15	6	40.0%	2	1	50.0%	6	6	0.0	-16	2	21	40.9%
11/4	NOP	W 123-105	35	21	11	4	0	0	1	3	2	66.7%	10	6	60.0%	13	8	61.5%	4	3	75.0%	2	9	4.0	+19	3	28	71.1%
11/1	WAS	W 130-121	23	8	11	2	0	0	5	2	0	0.0%	5	3	60.0%	7	3	42.9%	2	2	100.0%	4	7	0.4	+10	2	11	50.8%
10/30	MIN	W 127-113	33	12	5	3	1	1	2	2	1	50.0%	5	4	80.0%	7	5	71.4%	1	1	100.0%	1	4	1.5	+19	3	16	80.6%
10/29	MIL	W 127-110	25	14	7	1	1	2	2	3	2	66.7%	7	4	57.1%	10	6	60.0%	0	0	0.0%	1	6	0.5	+14	4	14	70.0%
10/27	NYK	L 126-120	29	11	9	2	1	1	3	2	0	0.0%	6	5	83.3%	8	5	62.5%	3	1	33.3%	0	9	0.7	-1	2	18	59.0%
10/25	CHA	L 116-110	29	21	7	2	1	2	0	3	1	33.3%	10	8	80.0%	13	9	69.2%	4	2	50.0%	0	7	0.0	+8	1	28	71.1%
Regular Season Totals			33.7	16.0	8.7	3.6	0.8	1.2	1.8	3.6	1.3	35.5%	9.0	5.1	57.4%	12.5	6.4	51.1%	2.6	1.9	72.8%	1.3	7.4	2.0	-76	2.4	23.9	58.4%

Jalen Johnson

#1 SF

Status

Previous game (vs. MIA 4/9)

Latest Jalen Johnson news

Out at least three weeks

2023-24 Season Stats

Jalen Johnson Career Stats

Career Averages

Career Averages

Jalen Johnson Season Stats

2024-25

2023-24

Previous Game (vs. MIA 4/9)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

Jalen Johnson Game Log

2024-25

2023-24

Jalen Johnson Player Profile

Career History

Jalen Johnson Fantasy Projections

It's the offseason! 😎

Jalen Johnson Latest News

Out at least three weeks

Won't play Wednesday

Won't return Tuesday

Grabs team-high 16 boards Thursday

First career triple-double

Returns to starting unit

Gets 25 minutes in return

Coming off bench Monday

Will return Monday

Jalen Johnson

#1 SF

Unlock the latest Atlanta Hawks news — direct to your inbox.

Status

Previous game (vs. MIA 4/9)

Latest Jalen Johnson news Subscribe

2023-24 Season Stats

Latest Jalen Johnson news